Cited by 192Sleep and Work-Related FatigueCircadian rhythm and melatoninCancer Risks and Factors

Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies

Open access
Travis, Ruth C., Balkwill, Angela, Fensom, Georgina K., Appleby, Paul N., Reeves, Gillian K., Wang, Xiao-Si, Roddam, Andrew W., Gathani, Toral +4 more·2016·Journal of the National Cancer Institute

Abstract

BACKGROUND: It has been proposed that night shift work could increase breast cancer incidence. A 2007 World Health Organization review concluded, mainly from animal evidence, that shift work involving circadian disruption is probably carcinogenic to humans. We therefore aimed to generate prospective epidemiological evidence on night shift work and breast cancer incidence. METHODS: Overall, 522 246 Million Women Study, 22 559 EPIC-Oxford, and 251 045 UK Biobank participants answered questions on shift work and were followed for incident cancer. Cox regression yielded multivariable-adjusted breast cancer incidence rate ratios (RRs) and 95% confidence intervals (CIs) for night shift work vs no night shift work, and likelihood ratio tests for interaction were used to assess heterogeneity. Our meta-analyses combined these and relative risks from the seven previously published prospective studies (1.4 million women in total), using inverse-variance weighted averages of the study-specific log RRs. RESULTS: In the Million Women Study, EPIC-Oxford, and UK Biobank, respectively, 673, 28, and 67 women who reported night shift work developed breast cancer, and the RRs for any vs no night shift work were 1.00 (95% CI = 0.92 to 1.08), 1.07 (95% CI = 0.71 to 1.62), and 0.78 (95% CI = 0.61 to 1.00). In the Million Women Study, the RR for 20 or more years of night shift work was 1.00 (95% CI = 0.81 to 1.23), with no statistically significant heterogeneity by sleep patterns or breast cancer risk factors. Our meta-analysis of all 10 prospective studies included 4660 breast cancers in women reporting night shift work; compared with other women, the combined relative risks were 0.99 (95% CI = 0.95 to 1.03) for any night shift work, 1.01 (95% CI = 0.93 to 1.10) for 20 or more years of night shift work, and 1.00 (95% CI = 0.87 to 1.14) for 30 or more years. CONCLUSIONS: The totality of the prospective evidence shows that night shift work, including long-term shift work, has little or no effect on breast cancer incidence.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/djw169

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 26 · Cited by 192

Authors
Travis, R. C., Balkwill, A., Fensom, G. K., Appleby, P. N., Reeves, G. K., Wang, X.-S., Roddam, A. W., Gathani, T., Peto, R., Green, J., Key, T. J., & Beral, V.
Affiliations
GlaxoSmithKline (United Kingdom) (GB)
Corresponding author
Travis, Ruth C.
Venue
Journal of the National Cancer Institute
Published
2016-10-06
Volume
108
Issue
12
Pages
djw169
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2528723127
Cited by
192
References
26
Citations by year
2026: 2 · 2025: 11 · 2024: 11 · 2023: 15 · 2022: 24 · 2021: 21 · 2020: 20 · 2019: 26 · 2018: 26 · 2017: 31 · 2016: 4 · 2014: 1
FWCI
3.82
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • JNCI Journal of the National Cancer Institute (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • Cancer Research UK (C570/ A16491, 16896, K02700X, MR/M012190/1, 16491, C8221/A19170, A16491, A19170)
  • Health and Safety Executive
  • Medical Research Council (M012190/1, C570/A16491, MR/M012190, MR/K02700X/1, C8221/A19170, MC_PC_12028, MR/M012190/1)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and Work-Related Fatigue
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
Keywords
night shift work, breast cancer incidence, circadian rhythm disruption, shift work, cancer risk, sleep patterns, women's health
MeSH terms
Adolescent, Adult, Aged, Breast Neoplasms, Circadian Rhythm, Female, United Kingdom, Humans, Middle Aged, Personnel Staffing and Scheduling, Prospective Studies, Surveys and Questionnaires, Work Schedule Tolerance, Incidence, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review